Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Part B Demo Partially Shielded From Congress By CBO Scoring

Executive Summary

Congressional Budget Office projects big savings from the activities of the Center for Medicare and Medicaid Innovation, making it challenging for Congress to repeal the center or interfere with certain projects.

You may also be interested in...



Trump’s HHS, CMS Leadership Choices Underscore Focus On ACA Reform

Rep. Tom Price and health policy consultant Seema Verma will spearhead Trump Administration efforts to reform the Affordable Care Act as HHS secretary and administrator of CMS, respectively.

Trump, Congress And The Future Of Value-Based Drug Contracting

CMS-driven experiments in value-based purchasing may slow in the new US administration but commercial pressures to price drugs according to their value will not.

Part B Demo Could Save $2.2 Bil., CBO Says; Blocking It Would Cost Less

CMS’ proposal to test alternate payment methods for Part B drugs could save as much as $2.2 billion over 10 years, the Congressional Budget Office told Congress. However, a bill to block implementation of the program would only cost $395 million for scoring purposes.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS119092

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel